Aelix Therapeutics, nominated by Johnson and Johnson Innovation, was selected to be a finalist at Falling Walls Venture held in November, 2016 in Berlin

Falling Walls Venture is an international forum for outstanding science based start-up companies, venture capitalists, opinion leaders and strategic investors as well as their wider academic and business environment.
By AELIX Therapeutics | March 28, 2016

Every year, twenty outstanding science based start-ups are selected from the nominations received from leading international academic institutions and international venture capitalists to present their most outstanding science based enterprises to an audience and a distinguished jury.